Sort
35,931 grants matching “parkinsons”
Anxiety and depression in a nonhuman primate model of synucleinopathy
$3,064,072Marina Emborg · University Of Wisconsin-Madison · RF1 · FY2025 · NS
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$3,058,626Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2023 · DA
Stanford Alzheimer's Disease Research Center
$3,053,045Victor W. Henderson · Stanford University · P30 · FY2021 · AG
Stanford Alzheimer's Disease Research Center
$3,051,859Victor W. Henderson · Stanford University · P30 · FY2022 · AG
Proteinopathies of the Aging Central Nervous System
$3,051,367Lennart Mucke · J. David Gladstone Institutes · P01 · FY2010 · AG
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$3,047,164Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2021 · HG
Basal Ganglia in Health and Disease
$3,046,163Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Proteinopathies of the Aging Central Nervous System
$3,028,460Lennart Mucke · J. David Gladstone Institutes · P01 · FY2009 · AG
Stanford Alzheimer's Disease Research Center
$3,015,406Victor W. Henderson · Stanford University · P30 · FY2020 · AG
Role of Tau Cleavage and Phosphorylation in Tauopathy
$3,014,543Karen H Ashe · University Of Minnesota · RF1 · FY2018 · AG
Investigating the Causal Role of Particulate Matter Components on Lewy Body Dementia: Integrating Epidemiologic and Mechanistic Evidence
$3,013,265Robbie M Parks · Columbia University Health Sciences · RF1 · FY2025 · NS
UCSD Alzheimer's Disease Research Center P50
$3,010,023James B Brewer · University Of California, San Diego · P50 · FY2016 · AG
2/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
$3,008,160Thomas Scott Stroup · Columbia University Health Sciences · R01 · FY2010 · MH
Investigating the neural mechanisms of human cognitive function through intracranial recordings
$3,000,706Kareem Zaghloul · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Center for Integrated Biomedical and Rural Health Research
$2,999,138Renee A Reijo Pera · Mc Laughlin Research Institute · P20 · FY2024 · GM
2/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
$2,997,389Thomas Scott Stroup · Columbia University Health Sciences · R01 · FY2011 · MH
Reactive oxygen species as early-in-life modulators of lifespan
$2,991,725Ursula H Jakob · University Of Michigan At Ann Arbor · RF1 · FY2025 · AG
EFFECTS RELATED BIOMAKERS OF TOXIC EXPOSURES
$2,990,583University Of Washington · P42 · FY2005 · ES
EFFECTS RELATED BIOMAKERS OF TOXIC EXPOSURES
$2,990,583University Of Washington · P42 · FY2004 · ES
NHGRI/DIR Bioinformatics and Scientific Programming Core
$2,982,046Andreas Baxevanis · National Human Genome Research Institute · ZIH · FY2009 · HG
Extracellular vesicle transport of brain-derived proteins to the blood in Alzheimer disease
$2,981,849Min Shi · University Of Washington · RF1 · FY2020 · AG
Regulation of Peripheral Proteostasis
$2,977,458Richard I. Morimoto · Northwestern University · RF1 · FY2017 · AG
HETEROGENEITY OF PARKINSON'S DISEASE PATIENTS IDENTIFICATION AND CHARACTERIZATION...
$2,976,272Rockefeller University · · FY2017 · Department of the Army
Basal Ganglia in Health and Disease
$2,967,142Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
Role of coordinated multi-area reactivations during transitions between automatic and flexible behaviors.
$2,965,125Karunesh Ganguly · University Of California, San Francisco · RF1 · FY2023 · NS